Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GHthis companyGuardant Health, Inc.	$160.18	-30.77×	-128.95×	13.04×	-37.81×	-214.8%	64.5%	-44.5%	-42.4%	419.2%	-25.1%	-1.8%	-17.22×	-3.56×	-112.2×	4.84×	0.0%	4	4.87	2	C
BDSXBiodesix, Inc.	$8.23	-1.46×	-20.83×	0.58×	-4.79×	-1313.6%	81.1%	-31.4%	-39.8%	1430.6%	-38.9%	-46.1%	-29.56×	-2.45×	-3.6×	1.86×	0.0%	4	-5.55	1	D+
BLLNBillionToOne, Inc.	$113.27	1,284.77×	7.81×	12.29×	170.11×	1225.6%	68.3%	5.3%	2.4%	1.6%	2.6%	0.4%	0.23×	-19.59×	168.66×	11.69×	0.0%	7	17.31	3	B-
CSTLCastle Biosciences, Inc.	$33.23	-46.87×	2.39×	3.28×	92.37×	-640.8%	79.4%	-12.4%	-7.0%	-5.1%	-6.8%	2.5%	0.08×	-7.04×	-497.79×	5.26×	0.0%	3	7.56	2	B-
FLGTFulgent Genetics, Inc.	$24.95	-13.34×	0.73×	2.51×	-16.71×	-77.3%	40.6%	-28.2%	-18.8%	-5.4%	-7.1%	-15.4%	0.01×	0.93×	-1,214.61×	6.48×	0.0%	5	4.47	3	B-
GRALGRAIL Inc.	$131.06	-7.7×	1.22×	21.37×	-7.92×	-125.0%	-42.5%	-363.0%	-277.5%	-15.8%	-14.3%	-9.5%	0.04×	0.4×	0×	11.97×	0.0%	4	7.44	2	C+
Peer median	—	-7.7×	1.22×	3.28×	-4.79×	-125.0%	68.3%	-28.2%	-18.8%	-5.1%	-7.1%	-9.5%	0.04×	-2.45×	-3.6×	6.48×	0.0%	4	7.44	2	—